In both PP2A transgenic mice and SLE patients, it has been demonstrated that PP2A increases the histone 3 acetylation at the Il17 gene locus and activates the transcription factor IRF4 in T cells resulting in an exaggerated immune response [49]. Here, IL17A is linked to systemic lupus erythematosus.